All articles tagged with #blood oxygen
Medical tech company Masimo is suing US Customs and Border Protection to challenge the decision allowing Apple to restore blood oxygen tracking on Apple Watches, claiming the agency failed to notify Masimo of the reversal of import restrictions and alleging patent infringement by Apple.
Masimo has filed a lawsuit against US Customs and Border Protection, alleging they overstepped their authority by reversing a decision that allowed Apple to reintroduce the Blood Oxygen feature on the Apple Watch, which Masimo claims infringes on its patents. The company seeks a court order to reinstate the original ruling and prevent the feature's reintroduction via software updates.
Masimo has sued US Customs and Border Protection, claiming it unlawfully reversed a decision that allowed Apple to restore a blood-oxygen monitoring feature on Apple Watches, which Masimo alleges infringes its patents. The company seeks to block the enforcement of CBP's recent ruling and restore the original decision that restricted imports of Apple Watches with the feature enabled, arguing the reversal was unlawful and violated procedural policies.
Apple has launched the public beta of watchOS 26, introducing a redesigned Blood Oxygen feature, allowing users to test new health monitoring capabilities before the official release.
Apple has released iOS 26 beta 7 and watchOS 26 beta 7, featuring a redesigned Blood Oxygen measurement tool for US users, which now supports background measurements and integrates with the iPhone for displaying results, after a previous patent dispute temporarily removed the feature from certain Apple Watch models.
Apple is releasing a software update to restore blood oxygen measurement features on certain US Apple Watch models, after a legal dispute led to the feature's removal. The update redesigns how blood oxygen data is presented, performing analysis on the iPhone instead of the watch itself, and is aimed at wellness rather than medical diagnosis. While studies suggest the device's readings are comparable to medical-grade pulse oximeters, concerns remain about accuracy and the clinical value of such wellness data.
Apple has announced a redesigned Blood Oxygen feature for certain Apple Watch models in the US, available through software updates iOS 18.6.1 and watchOS 11.6.1, with data measured on the paired iPhone and viewable in the Health app. The update restores the feature for models previously affected by a lawsuit, but only in the US and for specific series.
Apple has restored blood oxygen readings for U.S. Apple Watch Series 9, Series 10, and Ultra 2 users through a workaround in watchOS 11.6.1 and iOS 18.6.1, shifting data processing to the iPhone, which helps retain a key health feature ahead of new model releases amid declining smartwatch shipments.
Apple will restore blood oxygen measurement features to some of its Apple Watch models in the U.S. via a software update after U.S. Customs approved a revised technology following a patent dispute with Masimo, which had previously led to the removal of the feature in 2024.
Apple has released iOS 18.6.1 and watchOS 11.6.1, restoring the Blood Oxygen feature for U.S. users on Apple Watch Series 9, Series 10, and Ultra 2, following a patent dispute resolution enabled by a U.S. Customs ruling.
Apple is restoring the blood oxygen sensing feature to certain US-based Apple Watch Series 9, 10, and Ultra Watch 2 models via a software update, following a legal dispute with Masimo and a redesign of the feature. Users need to update their devices and paired iPhones to access this health feature, which is significant for fitness and health monitoring, especially amid increased health awareness during the pandemic.
Apple Watch models in the U.S. will regain blood oxygen tracking via a software update following a patent dispute with Masimo, with the feature now measured on the iPhone and available on Series 9, Series 10, and Ultra 2 models, just ahead of new product launches.
Apple has reintroduced blood oxygen monitoring to its latest Apple Watches through a software update that measures data on the paired iPhone to bypass an import ban, affecting models sold after January 17, 2024, while legal disputes with Masimo continue.
Apple is appealing a US import ban on its Apple Watch models with blood oxygen monitoring, arguing the ban was based on a patent dispute involving an undeveloped product, and has temporarily disabled this feature on recent models in the US while international versions retain full functionality. The case is ongoing, with a decision expected later this year.
Apple has removed the blood oxygen monitoring feature from the Apple Watch Series 9 and Ultra 2 in the U.S. due to a patent dispute with medical tech company Masimo. The feature has been removed from the devices and is non-functional, but it still works for existing users. However, the feature should continue to work on Apple Watch models sold outside the U.S. Apple has appealed the court's decision, leaving open the possibility of the feature being re-introduced in the future.